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Lyme Disease (LD) is currently the most common vector-borne disease in the United 
States1.  This disease is complicated to diagnose and cure in its acute state and highly morbid in 
its chronic state.  Given the complications derived from the presence of this pathogen , the  
varying antigenic response in its host and the difficulty to establish a timely diagnosis in at least 
half of the cases, we decided to focus our research on:  
a) Designing a new Diagnostic Protocol that will help with  faster identification of the  spirochete  
presence and associated co- infections,  plus help us establish a baseline  of autoimmune and 
degenerative diseases propensity in the affected individual. 
b)  Compiling  CAM (Complimentary and Alternative Medicine) treatments to compliment 
antibiotic therapies and prevent/treat co-morbidities associated with the chronic manifestation of 
Lyme. 
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Common Symptoms Lyme Babesia Anaplasma Bartonella 
Fatigue X X X X 
Headache X X X X 
Swollen joints X       
Fever X X X X 
Chills X X X X 
Swollen lymph nodes X     X 
Encephalopathy X X X   
Malaise X X X X 
Skin complications Bull’s eye rash   Rarely rash Rash 
Nausea/Vomiting   X X X 
Flu-like symptoms X X X X 
Muscle/joint aches X   X   
Confusion X   X   
Incubation Period 3 days -6 mo. 1-52 wks 1-30 days 3-50 days 
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Symptoms and Common Co-Infections: 
Typical symptoms of Lyme Disease overlap with other diseases transmitted by deer ticks, 
including Babesia microti, Anaplasma phagtocyphilum (formerly Ehrlichia phagocytophila), 
and Bartonella henselae 3-5. viruses such as TBEV, WNV, Powassan encephalitis, and other 
bacteria such as Q fever (Coxiella), Brucella, Tularemia, and Rickettsia species 10.Transmission 
of multiple pathogens by Ixodes ticks is common and can further complicate diagnosis, 
treatment and resolution of symptoms 6.  Mimickers of the disease in the chronic state are : 
Protozoan FL-1953, EBV, CMV, Mycoplasma, Chlamydia . See below for overlapping 
symptoms. 
Justification for More Comprehensive Testing: 
Concurrent tick-borne infections statistically decrease the likelihood of the characteristic bull’s 
eye rash and impairs diagnosis through conventional laboratory testing 6-8. Additionally, 
multiple tick-borne infections increase severity and duration of morbidity 6-8. Lyme disease is 
also a great mimicker of many chronic diseases including autoimmune and degenerative 
diseases, justifying the need for establishing a patient health baseline 9,11.   
Basic Laboratory Testing: 
Borrelia burgdorferi Ab ELISA with reflex to IgG & IgM Western blot: early disease to 
isolate antigenic response to Lyme 6 weeks post tick bite (its  reliability is controversial 11, false 
positive with other spirochetal disease, autoimmune disease, EBV, and periodontitis 12). 
-CBC with differential: abnormal WBCs, chronic anemia, hemolytic anemia 
-Comprehensive Metabolic Panel: imbalanced electrolyte levels, metabolic acidosis, elevated 
liver enzymes, BUN, uric acid, and creatinine 
 
Step One Comprehensive /Baseline Testing and Possible Findings 9,11,12: 
-Autoimmune Panel: increased morbidity if positive, easier follow up in chronic state 
-HLADR2, HLADR4 genotypes: increased morbidity if positive 
-Borrelia burgdorferi C6 Peptide Ab ELISA with reflex to IgG & IgM Western blot: more 
specific assay 
-Babesia microti, Anaplasma phagocytophilum, and Bartonella henselae Ab IgG & IgM by 
IFA: positive if co-infections are present 
-Viral Panel: to rule out other causes of symptoms 
-3-OH Vitamin D3: low 
-Thyroid Panel (TSH, TT4, FT4, Anti-TPO Ab, Anti-TG Ab): elevated TSH, maybe low 
TT4 and FT4, positive for antibodies 
-RBC Magnesium: < 2.0 
-CD-57 panel (Lab Corp): Absolute CD8-/CD57+ lymphocytes are often low in Lyme Disease 
and Chlamydia. Ideal range is >200.  
 
Step Two Comprehensive /Baseline Testing and Possible Findings 9,11,12: 
-Fasting Glucose, Insulin, HbA1c: altered glucose, elevated HbA1c, insulin resistance 
-Urinary Organic Acids and Amino Acids: elevated amino acids indicate a state of catabolic 
breakdown from disease, certain elevations in organic acids correlate with physiological 
malfunctions or infections 
-Fibrinogen: increased clotting factors 
-Anti-cardiolipin Ab, Anti-phospholipid Ab: positive if Borrelia burrows into the arterial 
lining 
-C3a and C4a (Lab Corp): elevated in Lyme and autoimmune disease 
Treatment therapies: (usually prescribed in this order)  
Oral: amoxicillin, azithromycin , cefuroxime , clarithromycin, doxycycline and tetracycline 
IV: ceftriaxone, cefotaxime, penicillin imipenem, azithromycin and doxycycline 
IM: benzathine penicillin 
Combination:  Oral amoxicillin, cefuroxime or cefdinir combined with a macrolide (azithromycin 
or clarithromycin) 
NSAIDS: for pain and inflammation 
 
CAM Treatments 9, 13: 
NK Cell and Phagocytotic Immune Boosting to Reduce Microbial Load: 
Antioxidants, Beta-glucans, Astragalus, Shiitake 
Inflammatory Cytokine Reduction:  
Samento, Cat’s Claw, Curcumin, Boswellia, Quercetin, Omega-3 Fatty Acids, Probiotics 
Anti-microbials:  
Olive leaf, colloidal silver, EGCG , Samento and Banderol to decrease biofilm formation 
A-L Complex (for Borrelia), A-BAB(for Babesia), A-BART (for Bartonella) 
Anti-virals: 
Lauricidin (monolauric acid) in coconut, L-lysine, Melissa officinalis,  Glycyrrhiza glabra 
Maintenance of Tight Junctions to Decrease Mobility of Infection: 
ALA, vitamin D, Ginkgo biloba, DHEA, Glutathione, NAC 
Dietary: Avoid sugar, gluten and casein; add protein to stabilize blood sugar and adrenal function,  
high water (1/2 body wt in oz.), high fiber, and alkaline diet high in vegetables 
Adjunct treatments: Hyperthermy –hot Epsom salt baths or IR sauna to trigger immune function , 
Hyperbaric Chamber: shown positive preliminary results 
Reduction of Increased Clotting: 
Hydrolytic enzymes, Capsaicin, Vitamin E, CoQ10, EPA/DHA 
 During a six year period cases of Lyme  disease were reported to CDC 
by 49 states and DC, the number of cases is increasing rapidly  
2 .   
CONCLUSIONS: After our thorough literary search we were able to design a 
protocol for comprehensive testing and consequent individualization of Lyme 
(and co-infection) treatments. Our preliminary data demonstrates that 
integrating antibiotic and CAM therapies help decrease the symptomatology 
and may prevent the chronic state of the disease by improving the immune 
system.  We look forward to implementing our lab test protocol as a standard 
for our clinic patients. We predict a reduction in chronic Lyme morbidity and 
more clarification on what pathology might be present  through better 
diagnostics and a combinatorial approach to treatment using CAM and 
antibiotics.  
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